Cargando…
Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Lung cancer is one of the most commonly diagnosed cancers and the leading cause of cancer-related deaths worldwide. Although progress in the treatment of advanced non-small cell lung cancer (NSCLC) has been made over the past decade, the 5-year survival rate in patients with lung cancer remains only...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771744/ https://www.ncbi.nlm.nih.gov/pubmed/29332322 http://dx.doi.org/10.4046/trd.2017.0120 |